CRN said regulators and digital platforms should treat AI-generated supplement ads using fake “doctors” as existing legal violations, not as standard industry practice.
The call followed a New York Times investigation showing marketers use artificial intelligence to create fictitious health experts who push supplements and make misleading disease-related claims.
CRN said the tactic speeds up deceptive marketing, weakens consumer trust and disadvantages compliant manufacturers that spend on research, quality and regulatory standards.
The trade group urged marketplaces to remove deceptive sellers and backed an FDA product registry, more FDA and FTC enforcement resources, and broader transparency across digital marketplaces.